Induction Therapy

During the induction phase, you will receive a combination of several different medications. The types of medication you receive will depend on your subtype of ALL. You may receive combination chemotherapytyrosine kinase inhibitor therapy, and CNS prophylaxis therapy.

The goal here is to kill as many leukaemia cells as possible in order to achieve remission, which means there are no detectable leukaemia cells in your blood or bone marrow. Induction therapy usually takes place over 4 to 6 weeks, most of which will be spent in the hospital. A high proportion of adults with newly diagnosed ALL enter complete remission after the initial treatment. However for some patients, several courses of induction therapy are needed to achieve remission. 


Join Our Community Register for Events Read Our Latest Blog

Page last updated on April 3, 2017